NOVAVAX Provides Update on Influenza Programs
24 juil. 2012 16h05 HE
|
Novavax, Inc.
Primary Endpoints Achieved in Phase II Seasonal Influenza Trial
Two H5N1 Pandemic Influenza Trials Fully Enrolled
ROCKVILLE, Md., July 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....
NOVAVAX and PATH Announce Partnership on RSV Vaccine
18 juil. 2012 08h00 HE
|
Novavax, Inc.
Novavax initially awarded approximately $2 million by PATH
Potential for future PATH funding of 50% of external costs to develop maternal RSV vaccine available for low-resource...
NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India
16 juil. 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., July 16, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), CPL Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB), today announced...
NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines
05 juil. 2012 09h02 HE
|
Novavax, Inc.
ROCKVILLE, Md., July 5, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) reported this week that Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax, reviewed recent...
Novavax to Review RSV Program at New International Conference on Modern Vaccines
27 juin 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., June 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax, will make a plenary...
NOVAVAX to Present at Jefferies 2012 Global Healthcare Conference
04 juin 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., June 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
NOVAVAX, Inc. Announces $12 Million Equity Offering
21 mai 2012 12h58 HE
|
Novavax, Inc.
ROCKVILLE, Md., May 21, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that on Friday, May 18, 2012, it sold 10,000,000 shares of its common stock to RA Capital Healthcare Fund,...
NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
09 mai 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., May 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment in a second Phase I clinical trial of its monovalent virus-like particle (VLP)...
NOVAVAX Reports First Quarter 2012 Financial Results
04 mai 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., May 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2012.
The company reported a net loss of $7.3...
NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
02 mai 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., May 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment in a Phase I clinical trial of its monovalent virus-like particle (VLP) vaccine...